Drug Type Small molecule drug |
Synonyms Gemcitabine/Docetaxel, NDV-01 |
Target |
Mechanism DNA inhibitors(DNA inhibitors), PSMA inhibitors(Prostate-specific membrane antigen inhibitors), RNR inhibitors(Ribonucleotide reductase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Muscle Invasive Bladder Neoplasms | Phase 2 | IL | 01 Aug 2024 |